HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistically acting agonists and antagonists of G protein-coupled receptors prevent photoreceptor cell degeneration.

Abstract
Photoreceptor cell degeneration leads to visual impairment and blindness in several types of retinal disease. However, the discovery of safe and effective therapeutic strategies conferring photoreceptor cell protection remains challenging. Targeting distinct cellular pathways with low doses of different drugs that produce a functionally synergistic effect could provide a strategy for preventing or treating retinal dystrophies. We took a systems pharmacology approach to identify potential combination therapies using a mouse model of light-induced retinal degeneration. We showed that a combination of U.S. Food and Drug Administration-approved drugs that act on different G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptors (GPCRs) exhibited synergistic activity that protected retinas from light-induced degeneration even when each drug was administered at a low dose. In functional assays, the combined effects of these drugs were stimulation of Gi/o signaling by activating the dopamine receptors D2R and D4R, as well as inhibition of Gs and Gq signaling by antagonizing D1R and the α1A-adrenergic receptor ADRA1A, respectively. Moreover, transcriptome analyses demonstrated that such combined GPCR-targeted treatments preserved patterns of retinal gene expression that were more similar to those of the normal retina than did higher-dose monotherapy. Our study thus supports a systems pharmacology approach to identify treatments for retinopathies, an approach that could extend to other complex disorders.
AuthorsYu Chen, Grazyna Palczewska, Ikuo Masuho, Songqi Gao, Hui Jin, Zhiqian Dong, Linn Gieser, Matthew J Brooks, Philip D Kiser, Timothy S Kern, Kirill A Martemyanov, Anand Swaroop, Krzysztof Palczewski
JournalScience signaling (Sci Signal) Vol. 9 Issue 438 Pg. ra74 (07 26 2016) ISSN: 1937-9145 [Electronic] United States
PMID27460988 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016, American Association for the Advancement of Science.
Chemical References
  • Adrenergic Agents
  • Dopamine Agents
  • Receptors, G-Protein-Coupled
Topics
  • Adrenergic Agents (pharmacology)
  • Animals
  • Dopamine Agents (pharmacology)
  • Gene Expression Regulation (drug effects)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Photoreceptor Cells, Vertebrate (metabolism, pathology)
  • Receptors, G-Protein-Coupled (agonists, antagonists & inhibitors, genetics, metabolism)
  • Retinal Degeneration (genetics, metabolism, pathology, prevention & control)
  • Signal Transduction (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: